Colorectal cancer mortality in two areas of Tuscany with different screening exposures

Journal of the National Cancer Institute

Volumn 100, Issue 24, 2008, Pages 1818-1821

  Costantini, Adele Seniori ^a   Martini, Andrea ^a   Puliti, Donella ^a   Ciatto, Stefano ^a   Castiglione, Guido ^a   Grazzini, Grazia ^a   Zappa, Marco ^a  

^a ISPO Cancer Prevention and Research Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; OCCULT BLOOD; POPULATION RISK; PRIORITY JOURNAL;

ADULT; AGED; COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; TIME FACTORS;

EID: 58049195702     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn404     Document Type: Article

References (15)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345-1389.
3. AIRTUM Working Group. I tumori in Italia - rapporto 2006. Incidenza, mortalità e stime. Epidemiol Prev. 2006;30(1):36-37.
4. World Health Organization. WHO International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Vols. 1-3. Geneva, Switzerland: World Health Organization; 1992-1994 .
5. AIRTUM Working Group. I tumori in Italia - rapporto 2006. Incidenza, mortalità e stime. Epidemiol Prev. 2006;30(1):114-115.
6. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. http://www.cochrane.org/reviews/en/ab001216.html. [Accessed November 1, 2006].
7. Zappa M, Castiglione G, Grazzini G, et al. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. Int J Cancer. 1997;73(2):208-210.
8. Arbyn M, Van Oyen H, Lynge E, Micksche M, Faivre J, Jordan J. European Commission's proposal for a council recommendation on cancer screening. BMJ. 2003;327(7409):289-290.
9. Castiglione G, Zappa M, Grazzini G, Sani C, Mazzotta, Mantellini P, Ciatto S. Cost analysis in a population based screening programme for colorectal cancer: comparison of immunochemical and guaiac faecal occult blood testing. J Med Screen. 1997;4 (3):142-146.
10. Grazzini G, Castiglione C, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev. 2004;13(1):19-26.
11. Gorini G, Zappa M, Miccinesi G, Paci E, Seniori Costantini A. Breast cancer of mortality trends in two areas of the province of Florence, Italy, where screening programmes started in the 1970s and 1990s. Br J Cancer. 2004;90(9):1780-1783.
12. StataCorp LP. Stata. Release 9.2. College Station, TX; 2006.
13. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut. 2002;50(1):29-32.
14. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet. 1996;348(9040):1472-1477.
15. Zappa M, Castiglione G, Paci E, et al. Measuring interval cancers in population based screening using different assays of fecal occult blood testing: the district of Florence experience. Int J Cancer. 2001;91:151-154.